CHS Moves Away From Isoflavones, Sells Solgen

635634801296576746soy heart.jpg

01 Apr 2015 --- Just three years after purchasing the Israeli soy protein firm, CHS, North America’s leading farmer-owned cooperative and a global energy, grains and foods company, announced it has sold Solgen isoflavone brand and related business to Tradichem S.L., Madrid, Spain.

Tradichem’s core business is the development and supply of pharmaceutical and nutraceutical ingredients. The transaction includes all CHS isoflavone inventory, the Solgen brand name and customer list, technology related to the product and the Solgen European Drug Master File.

“CHS recently ceased production of food-grade soy ingredients at its Ashdod, Israel, plant, and will no longer manufacture isoflavones,” said Tom Malecha, CHS vice president, Processing and Food Ingredients. “In addition to acquiring the Solgen inventory and related business assets, Tradichem will also assume all liabilities related to the former CHS isoflavone manufacturing, supply and distribution.”

Jose Angel Marañón, PhD., Tradichem executive director and director of research and development, said that Tradichem has been the CHS distributor of Solgen products for many years; making it a good fit within Tradichem’s portfolio. “We are proud to own the Solgen technology, inventory and brand and look forward to continuing to represent this outstanding product within our business,” said Marañón. 

Tradichem holds exclusive distribution agreements with global pharmaceutical and nutraceutical companies based in Israel, Germany, Switzerland and the US. Tradichem has built a culture of innovation to maximize the business growth, which is driven by initiatives underway at the Tradichem Innovation Center (TIC) laboratory, a research center hosted by Parque Científico de Madrid (PCM). 

To contact our editorial team please email us at editorial@cnsmedia.com

Related Articles

Nutrition & Health News

Bone and joint health: Consumer demands and promising ingredients

19 Apr 2018 --- Mobility, which incorporates bone and joint health, is becoming a key concern for a range of demographics. NutritionInsight spoke with a number of key suppliers in the bone and joint health space about the key ingredients to look out for, as well as some key consumer demands driving innovation in this space.

Nutrition & Health News

Plant-based possibilities: Report details novel sugar replacements for beverages

19 Apr 2018 --- PreScouter, a Chicago based technology scouting company, details novel replacements for sugars in a new analysis, that are from natural sources, safe, technologically viable and environmentally stable, for use in beverages. The company hopes that the report answers consumer calls for sweeteners that are both natural and healthy, in light of diabetes and obesity epidemics, and that it may aid informing beverage providers on how to best respond to calls for lowering sugar levels in drinks.

Nutrition & Health News

New study sheds light on non-celiac gluten avoidance

18 Apr 2018 --- People who avoid gluten in their diets, often avoid other food types – such as dairy and eggs – and are more likely to experience frequent adverse physiological symptoms after food consumption. The research sought to uncover why the popularity of gluten-free diets has risen so much amongst those who do not have medical gluten sensitivities.

Nutrition & Health News

Probiotic peanut allergy treatment: Chr. Hansen enters new partnership

18 Apr 2018 --- Probiotic strain, LGG, can potentially play a part in peanut allergy treatment. Prota Therapeutics, developer of oral immunotherapies to treat food allergies, has partnered with Chr. Hansen, Danish food ingredients producer, to assess LGG in a clinical trial to develop a treatment for the allergy. Chr. Hansen tells NutritionInsight that the partnership is in effect as from today, and strengthens the position of Chr. Hansen in a market expected to grow to €10billion by 2025.

Nutrition & Health News

Calls for sesame inclusion in US allergen labeling rules intensify

17 Apr 2018 --- US watchdog The Centre for Science in the Public Interest (CSPI) is stepping up its campaign urging the inclusion of sesame seeds in food to be clearly marked on the label as a potential allergen. In its latest report – Seeds of Change – the CSPI say that while some companies lead the way in sesame allergen labeling, large gaps remain.

More Articles
URL : http://www.nutritioninsight.com:80/news/CHS-Moves-Away-From-Isoflavones-Sells-Solgen.html